JP2013544069A5 - - Google Patents

Download PDF

Info

Publication number
JP2013544069A5
JP2013544069A5 JP2013512280A JP2013512280A JP2013544069A5 JP 2013544069 A5 JP2013544069 A5 JP 2013544069A5 JP 2013512280 A JP2013512280 A JP 2013512280A JP 2013512280 A JP2013512280 A JP 2013512280A JP 2013544069 A5 JP2013544069 A5 JP 2013544069A5
Authority
JP
Japan
Prior art keywords
cyclin
family
nuclear reprogramming
proteins
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013512280A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013544069A (ja
JP5888753B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2011/076017 external-priority patent/WO2012060473A1/en
Publication of JP2013544069A publication Critical patent/JP2013544069A/ja
Publication of JP2013544069A5 publication Critical patent/JP2013544069A5/ja
Application granted granted Critical
Publication of JP5888753B2 publication Critical patent/JP5888753B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013512280A 2010-11-04 2011-11-04 効率的な人工多能性幹細胞の樹立方法 Active JP5888753B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41017810P 2010-11-04 2010-11-04
US61/410,178 2010-11-04
PCT/JP2011/076017 WO2012060473A1 (en) 2010-11-04 2011-11-04 Method of efficiently establishing induced pluripotent stem cells

Publications (3)

Publication Number Publication Date
JP2013544069A JP2013544069A (ja) 2013-12-12
JP2013544069A5 true JP2013544069A5 (enExample) 2014-12-18
JP5888753B2 JP5888753B2 (ja) 2016-03-22

Family

ID=46024582

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013512280A Active JP5888753B2 (ja) 2010-11-04 2011-11-04 効率的な人工多能性幹細胞の樹立方法

Country Status (4)

Country Link
US (1) US9637732B2 (enExample)
EP (1) EP2635678A4 (enExample)
JP (1) JP5888753B2 (enExample)
WO (1) WO2012060473A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2624139C2 (ru) 2011-12-05 2017-06-30 Фэктор Байосайенс Инк. Способы и препараты для трансфекции клеток
US8497124B2 (en) 2011-12-05 2013-07-30 Factor Bioscience Inc. Methods and products for reprogramming cells to a less differentiated state
MX363017B (es) 2012-11-01 2019-03-04 Factor Bioscience Inc Métodos y productos para la expresión de proteínas en células.
JP2017510542A (ja) 2014-01-31 2017-04-13 ファクター バイオサイエンス インコーポレイテッド 核酸生成及び送達のための方法及び製品
EP3543339A1 (en) 2015-02-13 2019-09-25 Factor Bioscience Inc. Nucleic acid products and methods of administration thereof
IL305882B2 (en) 2016-05-25 2025-11-01 Inst Nat Sante Rech Med Methods for producing a population of inactivated pluripotent cells
CA3033788A1 (en) 2016-08-17 2018-02-22 Factor Bioscience Inc. Nucleic acid products and methods of administration thereof
CA3083158A1 (en) 2017-11-24 2019-05-31 Institut National De La Sante Et De La Recherche Medicale (Inserm) Methods and compositions for treating cancers
CN112703011A (zh) 2018-08-06 2021-04-23 国家医疗保健研究所 用于治疗癌症的方法和组合物
AU2020273728A1 (en) 2019-05-14 2021-11-18 Aleph Farms Ltd. Pluripotent cell aggregates and use thereof
US12344572B2 (en) 2019-07-03 2025-07-01 Factor Bioscience Inc. Cationic lipids and transfection methods
US10501404B1 (en) 2019-07-30 2019-12-10 Factor Bioscience Inc. Cationic lipids and transfection methods
AU2021388074A1 (en) 2020-11-24 2023-06-22 Monash University Methods and cellular structures
US12492372B2 (en) 2020-11-24 2025-12-09 Monash University Induced stem cells
US20240279612A1 (en) 2021-04-01 2024-08-22 Institut National de la Santé et de la Recherche Médicale Liver organoid manufacturing methods, liver organoids obtained with the same, and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ307399A0 (en) * 1999-09-24 1999-10-21 Luminis Pty Limited Cell cycle control
US9567591B2 (en) * 2003-05-15 2017-02-14 Mello Biotechnology, Inc. Generation of human embryonic stem-like cells using intronic RNA
CN101356270B (zh) 2005-12-13 2014-02-12 国立大学法人京都大学 核重新编程因子
EP2626416A3 (en) 2007-04-07 2013-12-18 The Whitehead Institute for Biomedical Research Reprogramming of somatic cells
EP2096169B1 (en) 2007-10-31 2020-11-18 Kyoto University Nuclear reprogramming method
WO2009091659A2 (en) * 2008-01-16 2009-07-23 Shi-Lung Lin Generation of tumor-free embryonic stem-like pluripotent cells using inducible recombinant rna agents
WO2009157201A1 (en) 2008-06-26 2009-12-30 Osaka University Method and kit for preparing ips cells
KR101606943B1 (ko) * 2008-06-27 2016-03-28 고쿠리츠 다이가쿠 호진 교토 다이가쿠 유도된 다능성 줄기 세포의 효율적인 확립 방법
KR101642790B1 (ko) 2008-07-07 2016-07-27 다카라 바이오 가부시키가이샤 다능성 줄기세포의 제조방법

Similar Documents

Publication Publication Date Title
JP2013544069A5 (enExample)
JP2011525793A5 (enExample)
JP2011529330A5 (enExample)
JP2012518988A5 (enExample)
JP2013517758A5 (enExample)
JP2018508198A5 (enExample)
EA201490703A1 (ru) Белковые каркасы на основе фибронектинового повтора типа iii с альтернативными поверхностями связывания
Al-Betar et al. Island-based harmony search for optimization problems
Wu et al. An implicit-gradient-enhanced incremental-secant mean-field homogenization scheme for elasto-plastic composites with damage
EA201892774A1 (ru) Антитела
EP3532075A4 (en) VIRAL METHODS OF MANUFACTURING GENETICALLY MODIFIED CELLS
EP2866284C0 (en) METHOD AND DEVICE FOR MANUFACTURING REACTIVE AGGLOMERATED PARTICLES, METHOD FOR MANUFACTURING ACTIVE SUBSTANCE FOR LITHIUM-ION BATTERY, AND LITHIUM-ION BATTERY AND METHOD FOR MANUFACTURING THE SAME
WO2009061442A8 (en) Method to produce induced pluripotent stem (ips) cells form non-embryonic human cells
JP2016500260A5 (enExample)
JP2014533491A5 (enExample)
AR089178A1 (es) Anticuerpos anti-il-36r
CL2013002361A1 (es) Metodo para medir actividad de células natural killer (nk); kit para medir dicha actividad; proteína de fusión; composicion para activar células nk; polipéptido, oligonucleótido, vector y célula hospedera que comprenden la proteína;
JP2011182800A5 (enExample)
EP3614470A4 (en) ADHESIVE FOR LITHIUM-ION ELECTRODE, ELECTRODE FOR LITHIUM-ION BATTERY AND ELECTRODE MANUFACTURING PROCESS FOR LITHIUM-ION BATTERY
EP4282881A3 (en) Antibodies against csf-1r
JP2013505701A5 (enExample)
JP2014005293A5 (enExample)
BR112014029274A2 (pt) anticorpo isolado, composição farmacêutica, uso do anticorpo, método para tratar infecção rábica, kit para tratar infecção rábica, kit para detectar vírus rábico, ácido nucleico isolado, e, célula hospedeira.
DE112019006656A5 (de) Batteriezellenmodul, positioniervorrichtung zur herstellung von batteriezellenmodulen und verfahren zur herstellung von batteriezellenmodulen
BRPI0908381A2 (pt) Sequência de ácido nucleico, transportador de ácido tricarboxílico mitocondrial, método para a produção de ácido itacônico, célula hospedeira, e, usos de uma proteína e da combinação de uma proteína com a enzima cad, e/ou um transportador mfs